Search

everythinglearnresearchcommunity

for

Search:↓

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Lower SHBG levels may increase the risk of PCOS.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Finasteride improves hair density and thickness in women with hair loss.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Spironolactone plus finasteride reduces hirsutism more effectively.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.